MyJournals Home  

RSS FeedsLong-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts (British Journal of Cancer)

 
 

14 november 2018 05:00:11

 
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts (British Journal of Cancer)
 




 
110 viewsCategory: Oncology
 
Effect of home-based specialised palliative care and dyadic psychological intervention on caregiver anxiety and depression: a randomised controlled trial (British Journal of Cancer)
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma (British Journal of Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten